Conversely, mastopathic-type fibroadenomas have less correlation with MED12 mutations and a low tendency for the proliferation of fibrous components, possibly allowing them to have ruffled borders and fat cell clusters near the tumor margins encompassed by peri-tumoral fat. The gene discussed is MED12; the disease is Fibroadenoma.